Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on nebulized midazolam, dexmedetomidine, and their combination for sedation in preschoolers undergoing dental treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (nebulized) (dexmedetomidine)
  • combined nebulized midazolam and dexmedetomidine
  • midazolam (nebulized) (midazolam)

Snippet

Sponsor: Nourhan M.Aly | Conditions: Dental Anxiety | Phase 2 | Status: COMPLETED